Physician profile
Brie B Baxter
NPI 1518410984
$471.61
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $79.19 · 2022: $80.47 · 2023: $260 · 2024: $51.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $221 · Food and Beverage: $91.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $220.90 |
| Food and Beverage | $91.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $236.00 | 2021-2023 | |
| Abbvie INC. | $95.63 | 2021-2024 | |
| Genentech USA, INC. | $42.50 | 2021-2022 | |
| Baxter Healthcare | $26.67 | 2022 | |
| Electromed, INC. | $24.23 | 2023 | Smartvest |
| Aimmune Therapeutics, INC. | $18.43 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $15.05 | 2023 | Trikafta |
| Gilead Sciences, INC. | $13.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brie Baxter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.